2018
DOI: 10.5604/01.3001.0011.7389
|View full text |Cite
|
Sign up to set email alerts
|

Antiproliferative Effects of Epigenetic Modifier Drugs through E-cadherin Up-regulation in Liver Cancer Cell Lines

Abstract: We were able to demonstrate Wnt/ β-catenin pathway modulation through E-cadherin up-regulation induced by 5aza-dC and TSA treatments, under an activation-pathway background, like CTNNB1 and TP53 mutations. These findings provide evidences of the potential effect of epigenetic modifier drugs for liver cancer treatment. However, further research needs to be conducted, to determine the in vivo potential of this treatment regimen for the management of liver cancer.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…DKK3 is a member of the DKK family, among which DKK-1, -2 and -4 compete for binding to the Wnt protein low-density lipoprotein 5/6 receptor ( 26 ). DKK3 negatively regulates β-catenin and its downstream signaling pathways by reducing β-catenin aggregation in the cytoplasm ( 27 ). The graphs presented in Fig.…”
Section: Discussionmentioning
confidence: 99%
“…DKK3 is a member of the DKK family, among which DKK-1, -2 and -4 compete for binding to the Wnt protein low-density lipoprotein 5/6 receptor ( 26 ). DKK3 negatively regulates β-catenin and its downstream signaling pathways by reducing β-catenin aggregation in the cytoplasm ( 27 ). The graphs presented in Fig.…”
Section: Discussionmentioning
confidence: 99%